A carregar...
Perspective on the role of Ozurdex (dexamethasone intravitreal implant) in the management of diabetic macular oedema
Diabetic macular oedema (DMO) is the most common cause of visual loss in the working age population. Intravitreal therapy has superseded macular laser as the first-line treatment for the management of centre-involving DMO in most patients. As well as the proven efficacy of intravitreal anti-vascular...
Na minha lista:
| Publicado no: | Ther Adv Chronic Dis |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
SAGE Publications
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4549694/ https://ncbi.nlm.nih.gov/pubmed/26336592 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2040622315590319 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|